Medical Care
Global CRISPR & Cas9 Market Research Report 2024
- Jan 20, 24
- ID: 18227
- Pages: 90
- Figures: 182
- Views: 30
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The global CRISPR & Cas9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR & Cas9 in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR & Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas9, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas9.
Report Scope
The CRISPR & Cas9 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR & Cas9 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR & Cas9 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR & Cas9 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global CRISPR & Cas9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR & Cas9 in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR & Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas9, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas9.
Report Scope
The CRISPR & Cas9 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR & Cas9 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR & Cas9 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR & Cas9 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas9 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas9 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas9 Market Perspective (2019-2030)
2.2 CRISPR & Cas9 Growth Trends by Region
2.2.1 Global CRISPR & Cas9 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR & Cas9 Historic Market Size by Region (2019-2024)
2.2.3 CRISPR & Cas9 Forecasted Market Size by Region (2025-2030)
2.3 CRISPR & Cas9 Market Dynamics
2.3.1 CRISPR & Cas9 Industry Trends
2.3.2 CRISPR & Cas9 Market Drivers
2.3.3 CRISPR & Cas9 Market Challenges
2.3.4 CRISPR & Cas9 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas9 Players by Revenue
3.1.1 Global Top CRISPR & Cas9 Players by Revenue (2019-2024)
3.1.2 Global CRISPR & Cas9 Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR & Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas9 Revenue
3.4 Global CRISPR & Cas9 Market Concentration Ratio
3.4.1 Global CRISPR & Cas9 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas9 Revenue in 2023
3.5 CRISPR & Cas9 Key Players Head office and Area Served
3.6 Key Players CRISPR & Cas9 Product Solution and Service
3.7 Date of Enter into CRISPR & Cas9 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas9 Breakdown Data by Type
4.1 Global CRISPR & Cas9 Historic Market Size by Type (2019-2024)
4.2 Global CRISPR & Cas9 Forecasted Market Size by Type (2025-2030)
5 CRISPR & Cas9 Breakdown Data by Application
5.1 Global CRISPR & Cas9 Historic Market Size by Application (2019-2024)
5.2 Global CRISPR & Cas9 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR & Cas9 Market Size (2019-2030)
6.2 North America CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR & Cas9 Market Size by Country (2019-2024)
6.4 North America CRISPR & Cas9 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR & Cas9 Market Size (2019-2030)
7.2 Europe CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR & Cas9 Market Size by Country (2019-2024)
7.4 Europe CRISPR & Cas9 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas9 Market Size (2019-2030)
8.2 Asia-Pacific CRISPR & Cas9 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR & Cas9 Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR & Cas9 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR & Cas9 Market Size (2019-2030)
9.2 Latin America CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR & Cas9 Market Size by Country (2019-2024)
9.4 Latin America CRISPR & Cas9 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas9 Market Size (2019-2030)
10.2 Middle East & Africa CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR & Cas9 Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR & Cas9 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Detail
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR & Cas9 Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR & Cas9 Business (2019-2024)
11.1.5 Caribou Biosciences Recent Development
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Detail
11.2.2 Integrated DNA Technologies(IDT) Business Overview
11.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Introduction
11.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2019-2024)
11.2.5 Integrated DNA Technologies(IDT) Recent Development
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Detail
11.3.2 CRISPR Therapeutics Business Overview
11.3.3 CRISPR Therapeutics CRISPR & Cas9 Introduction
11.3.4 CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024)
11.3.5 CRISPR Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck CRISPR & Cas9 Introduction
11.4.4 Merck Revenue in CRISPR & Cas9 Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Mirus Bio
11.5.1 Mirus Bio Company Detail
11.5.2 Mirus Bio Business Overview
11.5.3 Mirus Bio CRISPR & Cas9 Introduction
11.5.4 Mirus Bio Revenue in CRISPR & Cas9 Business (2019-2024)
11.5.5 Mirus Bio Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR & Cas9 Introduction
11.6.4 Editas Medicine Revenue in CRISPR & Cas9 Business (2019-2024)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio CRISPR & Cas9 Introduction
11.7.4 Takara Bio Revenue in CRISPR & Cas9 Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR & Cas9 Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR & Cas9 Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2019-2024)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Detail
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR & Cas9 Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024)
11.10.5 Intellia Therapeutics Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Detail
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies CRISPR & Cas9 Introduction
11.11.4 Agilent Technologies Revenue in CRISPR & Cas9 Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Cellecta
11.12.1 Cellecta Company Detail
11.12.2 Cellecta Business Overview
11.12.3 Cellecta CRISPR & Cas9 Introduction
11.12.4 Cellecta Revenue in CRISPR & Cas9 Business (2019-2024)
11.12.5 Cellecta Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript CRISPR & Cas9 Introduction
11.13.4 GenScript Revenue in CRISPR & Cas9 Business (2019-2024)
11.13.5 GenScript Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Detail
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia CRISPR & Cas9 Introduction
11.14.4 GeneCopoeia Revenue in CRISPR & Cas9 Business (2019-2024)
11.14.5 GeneCopoeia Recent Development
11.15 Synthego
11.15.1 Synthego Company Detail
11.15.2 Synthego Business Overview
11.15.3 Synthego CRISPR & Cas9 Introduction
11.15.4 Synthego Revenue in CRISPR & Cas9 Business (2019-2024)
11.15.5 Synthego Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas9 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas9 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas9 Market Perspective (2019-2030)
2.2 CRISPR & Cas9 Growth Trends by Region
2.2.1 Global CRISPR & Cas9 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR & Cas9 Historic Market Size by Region (2019-2024)
2.2.3 CRISPR & Cas9 Forecasted Market Size by Region (2025-2030)
2.3 CRISPR & Cas9 Market Dynamics
2.3.1 CRISPR & Cas9 Industry Trends
2.3.2 CRISPR & Cas9 Market Drivers
2.3.3 CRISPR & Cas9 Market Challenges
2.3.4 CRISPR & Cas9 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas9 Players by Revenue
3.1.1 Global Top CRISPR & Cas9 Players by Revenue (2019-2024)
3.1.2 Global CRISPR & Cas9 Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR & Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas9 Revenue
3.4 Global CRISPR & Cas9 Market Concentration Ratio
3.4.1 Global CRISPR & Cas9 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas9 Revenue in 2023
3.5 CRISPR & Cas9 Key Players Head office and Area Served
3.6 Key Players CRISPR & Cas9 Product Solution and Service
3.7 Date of Enter into CRISPR & Cas9 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas9 Breakdown Data by Type
4.1 Global CRISPR & Cas9 Historic Market Size by Type (2019-2024)
4.2 Global CRISPR & Cas9 Forecasted Market Size by Type (2025-2030)
5 CRISPR & Cas9 Breakdown Data by Application
5.1 Global CRISPR & Cas9 Historic Market Size by Application (2019-2024)
5.2 Global CRISPR & Cas9 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR & Cas9 Market Size (2019-2030)
6.2 North America CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR & Cas9 Market Size by Country (2019-2024)
6.4 North America CRISPR & Cas9 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR & Cas9 Market Size (2019-2030)
7.2 Europe CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR & Cas9 Market Size by Country (2019-2024)
7.4 Europe CRISPR & Cas9 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas9 Market Size (2019-2030)
8.2 Asia-Pacific CRISPR & Cas9 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR & Cas9 Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR & Cas9 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR & Cas9 Market Size (2019-2030)
9.2 Latin America CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR & Cas9 Market Size by Country (2019-2024)
9.4 Latin America CRISPR & Cas9 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas9 Market Size (2019-2030)
10.2 Middle East & Africa CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR & Cas9 Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR & Cas9 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Detail
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR & Cas9 Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR & Cas9 Business (2019-2024)
11.1.5 Caribou Biosciences Recent Development
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Detail
11.2.2 Integrated DNA Technologies(IDT) Business Overview
11.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Introduction
11.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2019-2024)
11.2.5 Integrated DNA Technologies(IDT) Recent Development
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Detail
11.3.2 CRISPR Therapeutics Business Overview
11.3.3 CRISPR Therapeutics CRISPR & Cas9 Introduction
11.3.4 CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024)
11.3.5 CRISPR Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck CRISPR & Cas9 Introduction
11.4.4 Merck Revenue in CRISPR & Cas9 Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Mirus Bio
11.5.1 Mirus Bio Company Detail
11.5.2 Mirus Bio Business Overview
11.5.3 Mirus Bio CRISPR & Cas9 Introduction
11.5.4 Mirus Bio Revenue in CRISPR & Cas9 Business (2019-2024)
11.5.5 Mirus Bio Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR & Cas9 Introduction
11.6.4 Editas Medicine Revenue in CRISPR & Cas9 Business (2019-2024)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio CRISPR & Cas9 Introduction
11.7.4 Takara Bio Revenue in CRISPR & Cas9 Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR & Cas9 Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR & Cas9 Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2019-2024)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Detail
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR & Cas9 Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024)
11.10.5 Intellia Therapeutics Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Detail
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies CRISPR & Cas9 Introduction
11.11.4 Agilent Technologies Revenue in CRISPR & Cas9 Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Cellecta
11.12.1 Cellecta Company Detail
11.12.2 Cellecta Business Overview
11.12.3 Cellecta CRISPR & Cas9 Introduction
11.12.4 Cellecta Revenue in CRISPR & Cas9 Business (2019-2024)
11.12.5 Cellecta Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript CRISPR & Cas9 Introduction
11.13.4 GenScript Revenue in CRISPR & Cas9 Business (2019-2024)
11.13.5 GenScript Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Detail
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia CRISPR & Cas9 Introduction
11.14.4 GeneCopoeia Revenue in CRISPR & Cas9 Business (2019-2024)
11.14.5 GeneCopoeia Recent Development
11.15 Synthego
11.15.1 Synthego Company Detail
11.15.2 Synthego Business Overview
11.15.3 Synthego CRISPR & Cas9 Introduction
11.15.4 Synthego Revenue in CRISPR & Cas9 Business (2019-2024)
11.15.5 Synthego Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CRISPR & Cas9 Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR & Cas9 Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global CRISPR & Cas9 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global CRISPR & Cas9 Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global CRISPR & Cas9 Market Share by Region (2019-2024)
Table 13. Global CRISPR & Cas9 Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global CRISPR & Cas9 Market Share by Region (2025-2030)
Table 15. CRISPR & Cas9 Market Trends
Table 16. CRISPR & Cas9 Market Drivers
Table 17. CRISPR & Cas9 Market Challenges
Table 18. CRISPR & Cas9 Market Restraints
Table 19. Global CRISPR & Cas9 Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global CRISPR & Cas9 Market Share by Players (2019-2024)
Table 21. Global Top CRISPR & Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2023)
Table 22. Ranking of Global Top CRISPR & Cas9 Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by CRISPR & Cas9 Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR & Cas9 Product Solution and Service
Table 26. Date of Enter into CRISPR & Cas9 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR & Cas9 Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global CRISPR & Cas9 Revenue Market Share by Type (2019-2024)
Table 30. Global CRISPR & Cas9 Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global CRISPR & Cas9 Revenue Market Share by Type (2025-2030)
Table 32. Global CRISPR & Cas9 Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global CRISPR & Cas9 Revenue Market Share by Application (2019-2024)
Table 34. Global CRISPR & Cas9 Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global CRISPR & Cas9 Revenue Market Share by Application (2025-2030)
Table 36. North America CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific CRISPR & Cas9 Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific CRISPR & Cas9 Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific CRISPR & Cas9 Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 51. Caribou Biosciences Company Detail
Table 52. Caribou Biosciences Business Overview
Table 53. Caribou Biosciences CRISPR & Cas9 Product
Table 54. Caribou Biosciences Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 55. Caribou Biosciences Recent Development
Table 56. Integrated DNA Technologies(IDT) Company Detail
Table 57. Integrated DNA Technologies(IDT) Business Overview
Table 58. Integrated DNA Technologies(IDT) CRISPR & Cas9 Product
Table 59. Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 60. Integrated DNA Technologies(IDT) Recent Development
Table 61. CRISPR Therapeutics Company Detail
Table 62. CRISPR Therapeutics Business Overview
Table 63. CRISPR Therapeutics CRISPR & Cas9 Product
Table 64. CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 65. CRISPR Therapeutics Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck CRISPR & Cas9 Product
Table 69. Merck Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Mirus Bio Company Detail
Table 72. Mirus Bio Business Overview
Table 73. Mirus Bio CRISPR & Cas9 Product
Table 74. Mirus Bio Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 75. Mirus Bio Recent Development
Table 76. Editas Medicine Company Detail
Table 77. Editas Medicine Business Overview
Table 78. Editas Medicine CRISPR & Cas9 Product
Table 79. Editas Medicine Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 80. Editas Medicine Recent Development
Table 81. Takara Bio Company Detail
Table 82. Takara Bio Business Overview
Table 83. Takara Bio CRISPR & Cas9 Product
Table 84. Takara Bio Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 85. Takara Bio Recent Development
Table 86. Thermo Fisher Scientific Company Detail
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific CRISPR & Cas9 Product
Table 89. Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Horizon Discovery Group Company Detail
Table 92. Horizon Discovery Group Business Overview
Table 93. Horizon Discovery Group CRISPR & Cas9 Product
Table 94. Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 95. Horizon Discovery Group Recent Development
Table 96. Intellia Therapeutics Company Detail
Table 97. Intellia Therapeutics Business Overview
Table 98. Intellia Therapeutics CRISPR & Cas9 Product
Table 99. Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 100. Intellia Therapeutics Recent Development
Table 101. Agilent Technologies Company Detail
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies CRISPR & Cas9 Product
Table 104. Agilent Technologies Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 105. Agilent Technologies Recent Development
Table 106. Cellecta Company Detail
Table 107. Cellecta Business Overview
Table 108. Cellecta CRISPR & Cas9 Product
Table 109. Cellecta Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 110. Cellecta Recent Development
Table 111. GenScript Company Detail
Table 112. GenScript Business Overview
Table 113. GenScript CRISPR & Cas9 Product
Table 114. GenScript Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 115. GenScript Recent Development
Table 116. GeneCopoeia Company Detail
Table 117. GeneCopoeia Business Overview
Table 118. GeneCopoeia CRISPR & Cas9 Product
Table 119. GeneCopoeia Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 120. GeneCopoeia Recent Development
Table 121. Synthego Company Detail
Table 122. Synthego Business Overview
Table 123. Synthego CRISPR & Cas9 Product
Table 124. Synthego Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 125. Synthego Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR & Cas9 Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CRISPR & Cas9 Market Share by Type: 2023 VS 2030
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR & Cas9 Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global CRISPR & Cas9 Market Share by Application: 2023 VS 2030
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR & Cas9 Report Years Considered
Figure 17. Global CRISPR & Cas9 Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global CRISPR & Cas9 Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global CRISPR & Cas9 Market Share by Region: 2023 VS 2030
Figure 20. Global CRISPR & Cas9 Market Share by Players in 2023
Figure 21. Global Top CRISPR & Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR & Cas9 Revenue in 2023
Figure 23. North America CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 25. United States CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 29. Germany CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific CRISPR & Cas9 Market Share by Region (2019-2030)
Figure 37. China CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 45. Mexico CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 49. Turkey CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Caribou Biosciences Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 52. Integrated DNA Technologies(IDT) Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 53. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 54. Merck Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 55. Mirus Bio Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 56. Editas Medicine Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 57. Takara Bio Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 59. Horizon Discovery Group Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 60. Intellia Therapeutics Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 61. Agilent Technologies Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 62. Cellecta Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 63. GenScript Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 64. GeneCopoeia Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 65. Synthego Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global CRISPR & Cas9 Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR & Cas9 Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global CRISPR & Cas9 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global CRISPR & Cas9 Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global CRISPR & Cas9 Market Share by Region (2019-2024)
Table 13. Global CRISPR & Cas9 Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global CRISPR & Cas9 Market Share by Region (2025-2030)
Table 15. CRISPR & Cas9 Market Trends
Table 16. CRISPR & Cas9 Market Drivers
Table 17. CRISPR & Cas9 Market Challenges
Table 18. CRISPR & Cas9 Market Restraints
Table 19. Global CRISPR & Cas9 Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global CRISPR & Cas9 Market Share by Players (2019-2024)
Table 21. Global Top CRISPR & Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2023)
Table 22. Ranking of Global Top CRISPR & Cas9 Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by CRISPR & Cas9 Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR & Cas9 Product Solution and Service
Table 26. Date of Enter into CRISPR & Cas9 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR & Cas9 Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global CRISPR & Cas9 Revenue Market Share by Type (2019-2024)
Table 30. Global CRISPR & Cas9 Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global CRISPR & Cas9 Revenue Market Share by Type (2025-2030)
Table 32. Global CRISPR & Cas9 Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global CRISPR & Cas9 Revenue Market Share by Application (2019-2024)
Table 34. Global CRISPR & Cas9 Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global CRISPR & Cas9 Revenue Market Share by Application (2025-2030)
Table 36. North America CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific CRISPR & Cas9 Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific CRISPR & Cas9 Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific CRISPR & Cas9 Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa CRISPR & Cas9 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa CRISPR & Cas9 Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa CRISPR & Cas9 Market Size by Country (2025-2030) & (US$ Million)
Table 51. Caribou Biosciences Company Detail
Table 52. Caribou Biosciences Business Overview
Table 53. Caribou Biosciences CRISPR & Cas9 Product
Table 54. Caribou Biosciences Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 55. Caribou Biosciences Recent Development
Table 56. Integrated DNA Technologies(IDT) Company Detail
Table 57. Integrated DNA Technologies(IDT) Business Overview
Table 58. Integrated DNA Technologies(IDT) CRISPR & Cas9 Product
Table 59. Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 60. Integrated DNA Technologies(IDT) Recent Development
Table 61. CRISPR Therapeutics Company Detail
Table 62. CRISPR Therapeutics Business Overview
Table 63. CRISPR Therapeutics CRISPR & Cas9 Product
Table 64. CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 65. CRISPR Therapeutics Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck CRISPR & Cas9 Product
Table 69. Merck Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Mirus Bio Company Detail
Table 72. Mirus Bio Business Overview
Table 73. Mirus Bio CRISPR & Cas9 Product
Table 74. Mirus Bio Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 75. Mirus Bio Recent Development
Table 76. Editas Medicine Company Detail
Table 77. Editas Medicine Business Overview
Table 78. Editas Medicine CRISPR & Cas9 Product
Table 79. Editas Medicine Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 80. Editas Medicine Recent Development
Table 81. Takara Bio Company Detail
Table 82. Takara Bio Business Overview
Table 83. Takara Bio CRISPR & Cas9 Product
Table 84. Takara Bio Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 85. Takara Bio Recent Development
Table 86. Thermo Fisher Scientific Company Detail
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific CRISPR & Cas9 Product
Table 89. Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Horizon Discovery Group Company Detail
Table 92. Horizon Discovery Group Business Overview
Table 93. Horizon Discovery Group CRISPR & Cas9 Product
Table 94. Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 95. Horizon Discovery Group Recent Development
Table 96. Intellia Therapeutics Company Detail
Table 97. Intellia Therapeutics Business Overview
Table 98. Intellia Therapeutics CRISPR & Cas9 Product
Table 99. Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 100. Intellia Therapeutics Recent Development
Table 101. Agilent Technologies Company Detail
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies CRISPR & Cas9 Product
Table 104. Agilent Technologies Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 105. Agilent Technologies Recent Development
Table 106. Cellecta Company Detail
Table 107. Cellecta Business Overview
Table 108. Cellecta CRISPR & Cas9 Product
Table 109. Cellecta Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 110. Cellecta Recent Development
Table 111. GenScript Company Detail
Table 112. GenScript Business Overview
Table 113. GenScript CRISPR & Cas9 Product
Table 114. GenScript Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 115. GenScript Recent Development
Table 116. GeneCopoeia Company Detail
Table 117. GeneCopoeia Business Overview
Table 118. GeneCopoeia CRISPR & Cas9 Product
Table 119. GeneCopoeia Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 120. GeneCopoeia Recent Development
Table 121. Synthego Company Detail
Table 122. Synthego Business Overview
Table 123. Synthego CRISPR & Cas9 Product
Table 124. Synthego Revenue in CRISPR & Cas9 Business (2019-2024) & (US$ Million)
Table 125. Synthego Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR & Cas9 Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CRISPR & Cas9 Market Share by Type: 2023 VS 2030
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR & Cas9 Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global CRISPR & Cas9 Market Share by Application: 2023 VS 2030
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR & Cas9 Report Years Considered
Figure 17. Global CRISPR & Cas9 Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global CRISPR & Cas9 Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global CRISPR & Cas9 Market Share by Region: 2023 VS 2030
Figure 20. Global CRISPR & Cas9 Market Share by Players in 2023
Figure 21. Global Top CRISPR & Cas9 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR & Cas9 as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR & Cas9 Revenue in 2023
Figure 23. North America CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 25. United States CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 29. Germany CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific CRISPR & Cas9 Market Share by Region (2019-2030)
Figure 37. China CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 45. Mexico CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa CRISPR & Cas9 Market Share by Country (2019-2030)
Figure 49. Turkey CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia CRISPR & Cas9 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Caribou Biosciences Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 52. Integrated DNA Technologies(IDT) Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 53. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 54. Merck Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 55. Mirus Bio Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 56. Editas Medicine Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 57. Takara Bio Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 59. Horizon Discovery Group Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 60. Intellia Therapeutics Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 61. Agilent Technologies Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 62. Cellecta Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 63. GenScript Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 64. GeneCopoeia Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 65. Synthego Revenue Growth Rate in CRISPR & Cas9 Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232